The cell free expression market presents significant opportunities in developing diverse biomolecules, driven by demand from pharmaceutical and biotech sectorsDublin, April 20, 2026 (GLOBE NEWSWIRE) - ...
Join Dr. Mariah Pierce, Technical Account Manager at Sino Biological, as she introduces Sino Biological's cutting-edge, high-throughput, cell-free expression platform. This platform facilitates the ...
Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...
Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle vaccines that mimic viruses at the molecular level, offering a powerful new ...
Ebihara Takashi has been the chief operating officer of GeneFrontier (GFC) since 2010, with a focus on advancing cell-free protein expression technologies, particularly the PURE system. He earned a ...
Opportunities lie in the expanding demand for protein therapeutics driven by chronic disease prevalence, advancements in cell-free systems, and personalized medicine. Growth is supported by companies ...